CIAM
SLS icon

Caitong International Asset Management’s SELLAS Life Sciences SLS Stock Holding History

Caitong International Asset Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.36K Sell
634
-60,078
-99% -$415K ﹤0.01% 1168
2026
Q1 		$257K Buy
60,712
+5,583
+10% +$25K 0.05% 325
2025
Q4 		$208K Buy
55,129
+44,296
+409% +$86.1K 0.05% 201
2025
Q3 		$17.4K Buy
10,833
+5,709
+111% +$10.2K 0.01% 773
2025
Q2 		$11.2K Buy
+5,124
New +$7.86K 0.01% 680

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Caitong International Asset Management's SLS Position: Q2 2026 in Review

Caitong International Asset Management reduced its SELLAS Life Sciences (SLS) stake by 99% in Q2 2026, selling an estimated $415K and leaving 634 shares worth $9.36K. The position accounts for ﹤0.01% of the portfolio, ranked #1168.

Caitong International Asset Management first reported a position in SLS in Q2 2025 and has held it in 5 quarters since. The position peaked at $257K in Q1 2026. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Caitong International Asset Management held 634 shares of SELLAS Life Sciences worth $9.36K as of Q2 2026.
  • Caitong International Asset Management sold 60,078 SELLAS Life Sciences shares in Q2 2026, an estimated $415K.
  • SELLAS Life Sciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1168 holding.
  • Caitong International Asset Management first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's SELLAS Life Sciences position peaked at $257K in Q1 2026.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.